3.0.0 4709 2023-01-11T13:26:02Z 2023-01-11T13:26:02Z House H HR 2014-05-21 113 From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. MARINO:H.R. 4709.Congress has the power to enact this legislation pursuantto the following:This bill is enacted pursuant to the power granted toCongress under Article I, Section 8, Clause 3 of the UnitedStates Constitution. The Constitution's Commerce Clauseallows Congress to enact laws when reasonably related to theregulation of interstate commerce.[Page H4785]]]> sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2014-07-30T18:15:08Z hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2014-05-23T17:48:35Z Reported by 2014-07-29T16:39:00Z Markup by 2014-06-10T20:08:07Z Referred to 2014-05-21T14:01:30Z hsju00 Judiciary Committee House Standing hsju08 Crime and Federal Government Surveillance Subcommittee Referred to 2014-07-21T14:36:59Z Referred to 2014-05-21T14:01:35Z H. Rept. 113-605 Ensuring Patient Access and Effective Drug Enforcement Act of 2013 113 4069 HR 2014-04-07 Subcommittee Hearings Held. Related bill CRS Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014 113 2862 S 2014-09-18 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Related bill CRS 2014-07-30 sshr00 Health, Education, Labor, and Pensions Committee Senate Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2014-07-29 14:57:21 Motion to reconsider laid on the table Agreed to without objection. Floor H38310 2 House floor actions 2014-07-29 14:57:19 On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7004-7005) Floor H37300 2 House floor actions 2014-07-29 14:57:19 Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H7004-7005) Floor 8000 9 Library of Congress 2014-07-29 14:37:42 DEBATE - The House proceeded with forty minutes of debate on H.R. 4709. Floor H8D000 2 House floor actions 2014-07-29 14:37:40 Considered under suspension of the rules. (consideration: CR H7004-7007) Floor H30000 2 House floor actions 2014-07-29 14:37:25 Mr. Pitts moved to suspend the rules and pass the bill, as amended. Floor H30300 2 House floor actions 2014-07-29 Reported by the Committee on Energy and Commerce. H. Rept. 113-605, Part I. Committee H12200 2 House floor actions hsif00 Energy and Commerce Committee 2014-07-29 Reported by the Committee on Energy and Commerce. H. Rept. 113-605, Part I. Committee 5000 9 Library of Congress hsif00 Energy and Commerce Committee 2014-07-21 hsju08 Crime and Federal Government Surveillance Subcommittee 1 House committee actions Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. Committee 2014-06-10 hsif00 Energy and Commerce Committee 1 House committee actions Ordered to be Reported (Amended) by Voice Vote. Committee 2014-06-10 hsif00 Energy and Commerce Committee 1 House committee actions Committee Consideration and Mark-up Session Held. Committee 2014-06-09 hsif00 Energy and Commerce Committee 1 House committee actions Committee Consideration and Mark-up Session Held. Committee 2014-05-23 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2014-05-21 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsju00 Judiciary Committee 2014-05-21 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2014-05-21 Introduced in House IntroReferral Intro-H 9 Library of Congress 2014-05-21 Introduced in House IntroReferral 1000 9 Library of Congress M001179 Rep. Marino, Tom [R-PA-10] Tom Marino R PA 10 N B001243 Rep. Blackburn, Marsha [R-TN-7] Marsha Blackburn R TN 7 2014-05-21 True W000800 Rep. Welch, Peter [D-VT-At Large] Peter Welch D VT 0 2014-05-21 True C001080 Rep. Chu, Judy [D-CA-27] Judy Chu D CA 27 2014-05-21 True S000244 Rep. Sensenbrenner, F. James, Jr. [R-WI-5] F. SENSENBRENNER R WI JAMES 5 2014-07-11 False H001065 Rep. Holding, George [R-NC-13] George Holding R NC 13 2014-07-15 False G000567 Rep. Griffin, Tim [R-AR-2] Tim Griffin R AR 2 2014-07-15 False C001093 Rep. Collins, Doug [R-GA-9] Doug Collins R GA 9 2014-07-15 False J000292 Rep. Johnson, Bill [R-OH-6] Bill Johnson R OH 6 2014-07-16 False S000583 Rep. Smith, Lamar [R-TX-21] LAMAR SMITH R TX 21 2014-07-22 False G000562 Rep. Gardner, Cory [R-CO-4] Cory Gardner R CO 4 2014-07-22 False A000369 Rep. Amodei, Mark E. [R-NV-2] Mark Amodei R NV E. 2 2014-07-23 False L000566 Rep. Latta, Robert E. [R-OH-5] Robert Latta R OH E. 5 2014-07-23 False Crime and Law Enforcement Administrative remedies Congressional oversight Department of Justice Drug trafficking and controlled substances Government information and archives Government studies and investigations Health care coverage and access Licensing and registrations Prescription drugs Retail and wholesale trades Crime and Law Enforcement 00 2014-05-21 Introduced in House 2014-09-08T19:58:21Z Ensuring Patient Access and Effective Drug Enforcement Act of 2014 - Amends the Controlled Substances Act to provide that: (1) a determination by the Attorney General that a registration to manufacture, distribute, or dispense a controlled substance is "consistent with the public health and safety" means that it has a substantial relationship to such Act's purpose of preventing diversion and abuse of controlled substances; and (2) a finding of "imminent danger" by the Attorney General justifying immediate suspension of such a registration means that there is a significant and present risk of death or serious bodily harm that is more likely than not to occur in the absence of such a suspension.

Requires the Attorney General, before revoking or suspending a registration under such Act, to: (1) provide the registrant notice of the grounds for doing so, and where such grounds consist of a legal violation, a specific citation to such law; (2) give the registrant an opportunity to submit a corrective action plan within a reasonable time period; and (3) determine whether, in light of the plan, revocation or suspension proceedings should be discontinued or deferred or additional changes need to be made in such plan.

Directs the Secretary of Health and Human Services (HHS), acting through the Commissioner of Food and Drugs (FDA) and the Director of the Centers for Disease Control and Prevention (CDC), to submit a report: (1) assessing how patient access to medications could be adversely impacted by federal and state law enforcement activities, and (2) identifying how collaboration between agencies and stakeholders can benefit patients and prevent diversion and abuse of controlled substances.

]]> 36 2014-07-29 Passed House amended 2015-01-06T21:56:04Z Ensuring Patient Access and Effective Drug Enforcement Act of 2014 - Amends the Controlled Substances Act to define: (1) "factors as may be relevant to and consistent with the public health and safety," for purposes of the Attorney General's determination of whether registering an applicant to manufacture or distribute a controlled substance in schedule I or II is in the public interest, as factors that are relevant to and consistent with the findings of such Act; and (2) "imminent danger to the public health or safety," for purposes of the suspension of such a registration, to mean that in the absence of an immediate suspension order, controlled substances will continue to be intentionally diverted outside of legitimate distribution channels or distributed or dispensed outside the usual course of professional practices or in a manner that poses a present or foreseeable risk of serious adverse health consequences or death.

Requires an order to show cause as to why such a registration should not be denied, revoked, or suspended to: (1) contain a statement of the basis for the denial, revocation, or suspension, including specific citations to any laws or regulations alleged to be violated; (2) direct the applicant or registrant to appear before the Attorney General at a specific place and time within 30 days after receipt of the order; and (3) notify the applicant or registrant of the opportunity to submit a corrective action plan on or before such appearance. Requires the Attorney General, upon review of any such plan, to determine whether denial, revocation, or suspension proceedings should be discontinued or deferred for purposes of modifications to such plan. Makes such requirements inapplicable to the issuance of an immediate suspension order.

Directs the Secretary of Health and Human Services (HHS), acting through the Commissioner of Food and Drugs (FDA) and the Director of the Centers for Disease Control and Prevention (CDC), to submit a report identifying: (1) obstacles to legitimate patient access to controlled substances; (2) issues with diversion of controlled substances; and (3) how collaboration between federal, state, local, and tribal law enforcement agencies and the pharmaceutical industry can benefit patients and prevent diversion and abuse of controlled substances.

]]> Ensuring Patient Access and Effective Drug Enforcement Act of 2014 Display Title Ensuring Patient Access and Effective Drug Enforcement Act of 2014 Official Title as Introduced To improve enforcement efforts related to prescription drug diversion and abuse, and for other purposes. Introduced in House IH Short Titles as Introduced Ensuring Patient Access and Effective Drug Enforcement Act of 2014 Short Titles as Passed House Ensuring Patient Access and Effective Drug Enforcement Act of 2014 H House Referred in Senate 2014-07-30T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-113hr4709rfs/xml/BILLS-113hr4709rfs.xml Engrossed in House 2014-07-29T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-113hr4709eh/xml/BILLS-113hr4709eh.xml Introduced in House 2014-05-21T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-113hr4709ih/xml/BILLS-113hr4709ih.xml 2014-07-30 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.